Patient Experience in Clinical Trials: Challenges and Tools

Written by
Florentin Ory
Published on
June 26, 2026

In a clinical trial, patient experience is not only about participant comfort. It influences protocol understanding, adherence to visits, questionnaire completion, and the quality of the data collected.

We often talk about patient experience, but the term "participant" is sometimes more accurate. Not all trials involve patients only: some studies include healthy volunteers, users, consumers, or participants in post-market studies.

For sponsors and CROs, participant experience is therefore becoming a feasibility issue. A journey that is too complex, poorly explained, or too burdensome to follow can increase the risk of missed visits, incomplete data, and avoidable dropouts.

What Do We Mean by Patient Experience in Clinical Trials?

Patient experience refers to all the interactions a participant goes through during the study: initial information, consent, enrollment, visits, questionnaires, reminders, exchanges with the site, remote follow-up, and end of participation.

It does not depend on a single tool. It relies on the consistency of the journey: what the participant understands, what they need to do, how much time it takes, which channels are used, and the quality of the research team's follow-up.

A good journey does not simply aim to be pleasant. It must be clear, accessible, realistic, and compatible with the constraints of the protocol.

Why Participant Experience Has Become a Study Conduct Issue

Protocols are often more demanding than they appear from the participant's perspective. Repeated visits, frequent questionnaires, travel, instructions to follow, visit windows, sampling, examinations, home-based or remote follow-up: each element adds burden.

This burden can weigh on study conduct. A participant who is poorly supported, over-solicited, or faced with heavy logistics has a higher risk of disengagement. The consequences are concrete: additional reminders, missing data, visit delays, increased burden for sites, and loss of usable data.

This approach is also reinforced by recent regulatory and methodological developments. The FDA structured its Patient-Focused Drug Development initiative to better integrate patient experience, needs, and priorities into medical development. ICH E6(R3) also reinforces the principles of participant protection, quality by design, and appropriate use of technologies in clinical trials.

Participant experience is therefore not a peripheral topic. It directly affects the operational quality of the study.

Datacapt

Let's Shape the Future of Clinical Trial Together!

What Are the Main Friction Points for Participants?

Friction points often appear in very concrete details.

An overly dense consent form can make understanding more difficult. Long or repetitive questionnaires can create fatigue. Poorly configured reminders can lead to missed entries. An unclear interface can discourage data entry. Too many visits, or poorly coordinated visits, can weigh on participant availability.

The most frequent friction points concern:

  • understanding the protocol
  • clarity of consent
  • visit frequency
  • questionnaire length
  • entry windows
  • travel
  • reminders
  • access to digital tools
  • visibility on next steps

The objective is not to remove every constraint. A protocol necessarily imposes requirements. The challenge is to distinguish useful scientific constraints from avoidable irritants.

What Levers Can Improve Patient Experience?

A smoother participant experience is built from the study design stage. It cannot be corrected only after launch.

Clarify Information from the Start

Participants must understand what is being asked of them, why it is being asked, and what will happen next. Consent is a key moment in this understanding.

An eConsent journey can help structure information, track versions, and facilitate access to documents. It does not replace the exchange with the research team, but it can make the process clearer and better documented.

Simplify the Participation Journey

Each visit, questionnaire, or reminder must have a clear purpose. When the protocol allows it, some elements can be completed remotely: electronic questionnaires, teleconsultations, home visits, or hybrid follow-up.

These approaches are particularly useful in hybrid or decentralized trials, provided they remain compatible with the scientific, regulatory, and operational requirements of the study.

Make Patient Data Entry Easier

Electronic patient questionnaires, or ePRO, allow participants to enter their data from their own device or from a device provided by the study. ePROs are part of the broader eCOA field when data reported by participants are used as clinical outcome measures.

The value of ePRO does not come only from moving to digital. It mainly depends on how questionnaires are designed: length, frequency, language, usability, reminders, entry windows, and conditional logic.

A questionnaire that is too long or poorly positioned in the journey can generate incomplete data. A clear, accessible questionnaire sent at the right time improves the chances of obtaining usable data.

Better Support Participants

Email or SMS reminders, notifications, QR codes, and personalized messages can reduce missed entries and manual follow-up.

But automation must remain controlled. Too many reminders create noise. Too few reminders create omissions. The right balance depends on the protocol, the participant profile, and the level of risk associated with the data collected.

Which Tools Can Structure This Approach?

Digital tools are useful when they structure study touchpoints without adding complexity for participants or teams.

A coherent approach can combine:

  • eConsent to frame and trace consent
  • ePRO to collect data directly from participants
  • eCRF to structure clinical data entered by sites
  • email or SMS reminders to reduce missed entries
  • QR codes to simplify access to questionnaires
  • dashboards to track missing data
  • roles and permissions to control access
  • the audit trail to preserve traceability of actions

Data management must remain secure, with controlled access, clear traceability, and an organization aligned with GDPR and applicable GCP requirements.

Why Patient Experience Also Improves Data Quality

Participant experience and data quality are connected. A questionnaire that is too complex, instructions that are poorly understood, or a missing reminder can generate missing data, corrections, or additional exchanges with the site.

Conversely, a clear journey helps collect the right data at the right time. Questionnaires are completed more consistently, missed entries are more visible, reminders are more targeted, and teams can more easily track study progress.

For sponsors and CROs, the benefits are both operational and scientific:

  • fewer missing data
  • fewer manual reminders
  • better visibility on participant adherence
  • better coordination with sites
  • more precise tracking of expected questionnaires and visits
  • data that are easier to use at the end of the study

Quality therefore does not depend only on controls applied after data collection. It is also built through the way participants experience the study journey.

How to Design a Smoother Participant Experience

The first step is to review the protocol from the participant's point of view. How many visits are planned? At what times? Which questionnaires must be completed? How long do they take? Which reminders are needed? What happens if data are missing?

This mapping helps identify friction points before the study opens. It also helps select the right tools: electronic consent, ePRO questionnaires, reminders, calendar, missing data tracking, multilingual access, or participant support.

Patient experience is not simply about adding a digital layer. It is about making the journey clearer, more consistent, and easier to follow, without weakening the protocol requirements.

Conclusion

A good patient experience facilitates participation and reduces avoidable irritants throughout the study.

For clinical teams, the topic is therefore not only relational. It is operational. A well-designed participant journey helps sites better monitor the study, sponsors better manage data collection, and participants more easily follow the steps planned by the protocol.

Florentin Ory
CEO & Co-Founder

Florentin combines clinical research know-how with a true passion for product design. Attentive to detail and obsessed with user experience, he ensures that Datacapt remains a high-performance platform that’s also intuitive and accessible to every user.

Blog & News Datacapt

News, Articles, Resources et Tutorials.